Trexquant Investment LP Invests $8.05 Million in The Clorox Company (NYSE:CLX)

Trexquant Investment LP bought a new position in The Clorox Company (NYSE:CLXFree Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 49,593 shares of the company’s stock, valued at approximately $8,054,000.

Several other large investors have also recently modified their holdings of CLX. Vanguard Group Inc. boosted its stake in shares of Clorox by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock valued at $2,518,517,000 after purchasing an additional 124,428 shares during the period. State Street Corp boosted its position in Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after buying an additional 245,525 shares during the period. Geode Capital Management LLC grew its holdings in Clorox by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock worth $501,925,000 after acquiring an additional 69,969 shares during the last quarter. Stifel Financial Corp increased its position in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Norges Bank bought a new position in shares of Clorox during the fourth quarter valued at about $259,041,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Barclays cut their price objective on Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a research report on Thursday, March 27th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Finally, Wells Fargo & Company lowered their price target on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a research report on Wednesday. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average price target of $159.00.

Read Our Latest Report on CLX

Clorox Stock Up 0.6 %

Clorox stock opened at $148.55 on Friday. The firm has a market cap of $18.30 billion, a price-to-earnings ratio of 40.59, a PEG ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a fifty day simple moving average of $150.37 and a two-hundred day simple moving average of $158.59.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the business posted $2.16 earnings per share. Equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.